Tacke, MD, PhD U, Uosukainen, MSci (Pharm) H, Kananen, BSci (Pharm) M, Kontra, Pharm Lic K, Pentikäinen, MD H. A pilot study about the feasibility and cost-effectiveness of electronic compliance monitoring in substitution treatment with buprenorphine—naloxone combination. J of Opioid Management [Internet]. 2018 Jan. 29 [cited 2024 Nov. 24];5(6):321-9. Available from: https://wmpllc.org/ojs/index.php/jom/article/view/950